RxDoctor Payments Data

Dawn Yonkee

Family · Plant City, FLNPI 1912217464

Payments from drug & device makers

$8,300in general payments, 2019–2025

Across 473 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • AstraZeneca$773
  • AbbVie$735
  • Boehringer Ingelheim$655
  • Pfizer$651
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$8,293100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,300 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$162,577
Medicare patients
360
Services billed
2,921

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin228$239,273
MounjaroTirzepatide119$134,311
OzempicSemaglutide82$94,598
EliquisApixaban81$81,608
JanuviaSitagliptin Phosphate50$56,821
FarxigaDapagliflozin Propanediol24$28,489
TrulicityDulaglutide20$19,421
LinzessLinaclotide18$13,649
Tresiba Flextouch U-100Insulin Degludec13$13,009
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$12,065
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$11,800
MultaqDronedarone Hcl11$8,432
Spiriva RespimatTiotropium Bromide11$5,709
TradjentaLinagliptin11$5,398
Levothyroxine Sodium428$4,338

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$655$250,380250 claims
Lilly USA, LLCMounjaro, Trulicity$1,070$153,732139 claims
Novo NordiskOzempic$1,297$94,59882 claims
PfizerEliquis$651$81,60881 claims
MerckJanuvia$60$56,82150 claims
AstraZenecaFarxiga$773$28,48924 claims
AbbVieLinzess$735$13,64918 claims
GSKTrelegy Ellipta$217$11,80011 claims
Sanofi-aventis U.S. LLCMultaq$53$8,43211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.

Other family in Plant City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →